Tizanidine
Product Images NDC 63874-087

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 63874-087). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Altura Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image For 2mg (63874 0087 30 1)

This is a description of a medication called Tizanidine HCL which contains 2mg tablets of Tizanidine Hydrochloride. It is a prescription drug that should be kept out of children's reach. For full disclosure on dosage, indications, and precautions, refer to the disclosure book. It is packaged by Altura Pharmaceuticals Inc. in Santa Fe Springs, CA 90670.*

FDA Label Image

Fig1 (Fig1)

FDA Label Image

Fig2 (Fig2)

This text describes the results of a study evaluating the improvement in Ashworth Score using a drug called Zanidine at a mean dose of 28.6 mg. The study lasted for a total of 7 weeks and the endpoint of the maintenance phase was observed at week 7 using the Last Observation Garred Forward method.*

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.